The Kymanox® Design, Development, and Commercialization team developed a prefilled, preassembled, large volume wearable injector as a platform device to be used by multiple pharmaceutical companies.


Kymanox needed to identify the device requirements, solidify intellectual property (IP), and develop a plan for design and manfuacture of the device.


Kymanox consolidated and distilled device requirements from patients, providers, critical component manufacturers (i.e. glass and rubber), automation vendors, contract filling companies, and contract manufacturers. Kymanox then created an industry-leading intellectual property portfolio which provided patients with an exceptional experience and built brand value for pharma partners. Lastly, Kymanox cultivated in-house expertise in both design and manufacture of the device in order to maintain control over development timelines and cost.


The Kymanox Design, Development, and Commercialization team generated IP and developed leading technologies for needle insertion and container access mechanisms in conjunction with a fully integrated prefilled, preassembled system. Kymanox completed a successful clinical trial with one of the industry’s first, pre-filled, pre-assembled wearable injectors
and produced a Good Manufacturing Process (GMP) ready-to-fill primary container configuration to be filled on existing syringe filling lines.